Partnership Opportunities
As potency assay development continues to be a consistent analytical bottleneck, slowing the pathway to regulatory approval, the 2nd Cell Therapy Potency Assay Summit is your ultimate platform to network and connect with the leaders across the cell therapy field.
We’ll work with you to build a bespoke partnership package focused on making valuable connections, cementing your role as the industry partner of choice, and generating actionable leads to ensure you meet your 2023 commercial objectives.
Get in touch to discuss your partnership options.
Can You Help this Industry?
Partner with us to expand your network and establish new business with 100+ VPs, Directors, and Senior Scientists who are searching for partners who can:
1.
Implement time efficient
and cost-effective
methods of
cell characterization
2.
Revolutionize their approach to potency assay development with the most advanced technology options
3.
Support in overcoming regulatory hurdles with services focused around an understanding of licensing guidelines
What's in it for You?
- Position Yourself as an Industry Thought Leader
Now is your chance to get in front of your target key decision makers in the market and demonstrate your expertise through podium presentations, moderating panel discussions or interactive roundtables. - Raise Brand Awareness
Increase your reach and exposure to new clients, customers and businesses through unique branding opportunities pre and post conference. - Meet and Network with Industry Pioneers
With a room full of drug developers looking to see how they can effectively measure potency, fill your pipeline with new leads for 2022 and beyond through one-to-one meetings and networking opportunities. - Benefit from Market Intelligence
Discover what solutions and services biopharma companies will be investing in to accelerate analytical development in 2022 to enable you to match your solutions accordingly.
Email sponsor@hansonwade.com to learn how we can help you achieve your business goals faster, more effectively, and more cost-efficiently for 2022 and beyond.
"Enjoyed the high quality of speakers! It was exactly what I was looking for on this topic. The talks felt very collaborative. Event staff went above and beyond."
Director - Global Biopharma Marketing , Cell & Gene Therapies, Agilent Technologies - 2022 Partner
